Siemens
Siemens Healthineers Dx Revenues Rise 1 Percent, Overall Revenues up 6 Percent
The company said that growth in its diagnostics business was partly offset by declines in the Americas and China.
Advanced Biological Laboratories Inks Licensing Deal for Siemens Healthineers' PCR Technologies
The deal will let ABL commercialize tests equivalent to those that had been offered by the shuttered Siemens subsidiary Fast Track Diagnostics.
Siemens Healthineers Ending Support for Legacy Systems Starting in 2025 as It Focuses on Atellica
Premium
The company consolidated its instrument lineup with its newer Atellica instruments and is phasing out support for Advia and Dimension branded analyzers through 2030.
Qiagen, Danaher, Thermo Fisher Scientific, Others Gain 510(k) Clearances in October
The US Food and Drug Administration granted clearances for various tests for infectious diseases, coagulation disorders, and drug susceptibility.
Siemens Healthineers Reports Leaner, More Profitable Dx Business Poised for Growth Amid Transformation
The firm reported that its adjusted diagnostics revenues rose less than 1 percent, excluding the COVID-19 rapid antigen testing business that the firm exited last year.
Aug 5, 2024
Jul 29, 2024